Abstract
Introduction
Atherosclerosis was known as a devastating and life-threatening disease that is characterized by an accumulation of fibrous elements and lipids in large arteries and is the leading cause of mortality and morbidity worldwide [1, 2] . It is believed that endothelial cells apoptosis results in the denudation or dysfunction of the intact endothelial monolayer, which causes lipid accumulation, monocyte adhesion, and inflammatory reactions leading to atherosclerotic lesion [3] .
Traditional analysis regarding the polymorphism in IS patients just focused on the genotype frequency in patients and control samples. Currently, miRNA has been documented as function factor involved in the SNP associated post-transcriptional regulation [4, 5] . The binding of certain miRNA could be influenced in different genotypes causing the different expression of mRNA level with [6, 7] . MiRNA are small, non-coding RNA molecules. MicroRNAs (miRNAs) are a family of small noncoding RNAs with 20-25 nucleotides, which function through binding to their complementary sites on the 3'-UTR of target mRNAs to mediate mRNA degradation and translation repression [8, 9] . Through binding to the 3' untranslated region (3'-UTR) of messenger RNA (mRNA), miRNA can cause degradation of mRNA, thus regulating the expression of mRNA at post-transcription level [10] . Genetic variations in the 3'-UTR of certain genes are able to change the expression of the genes and alter the risk of a variety of human cancers [6] . Thus, in this study, we assessed genetic variants in the MTHFR 3'-UTR in atherosclerosis patients and healthy control individuals, and then associated these genetic variants with miRNA levels using a case-control study design in a Chinese Han population.
Methylene tetrahydrofolate reductase (MTHFR) is the key enzyme for the metabolism of circulating homocysteine (tHcy) [11] . This plays an important role in the regulation of cell signaling and homeostasis. During stress, ROS levels can be increased dramatically, resulting in cell structure damage [12] . For example, upregulated tHcy can induce cell apoptosis by increased ROS levels through activation of the p38 MAPK pathway [13] . This plays an important role in the regulation of cell signaling and homeostasis. MTHFR is localized at chromosome 1 p36.3 of human genome, and to date there are over 40 point mutations or SNPs in the MTHFR gene identified [14, 15] . The polymorphism 1801133 involves substitution of C to T at position 677 (C677T), causing the conversion of alanine to valine. This missense mutation will result in approximately 70% and 35% reductions of normal MTHFR enzymatic activity in TT and CT genotype carriers [16, 17] .
Materials and Methods

Study subjects
In this study, we enrolled 500 patients diagnosed with atherosclerosis from Zhengzhou Central Hospital Affiliated to Zhengzhou University between July 2009 and April 2016. Diagnosis of patients with atherosclerosis was established clinically. We also recruited 600 healthy volunteers from this hospital during the same period of time and they were matched to the cases by age and gender. All control individuals visited our hospital for annual health check-ups and were free of atherosclerosis. This study was approved by the Ethics Committee of Zhengzhou University and each participant signed a written informed consent.
Bioinformatic analysis of miRNAs binding to MTHFR SNP and linkage disequilibrium analysis among MTHFR polymorphisms
Bioinformatics software (http://bioinfo.life.hust.edu.cn/miRNASNP2/) was used to detect the candidate SNPs which could affect MTHFR gene regulation via miRNAs.
Genomic DNA extraction and genotyping Blood samples were collected after a 12h overnight fasting period and then separated into serum, red blood cells, and buffy coat. Genomic DNA from peripheral whole blood of every validation subject was extracted by using QIAamp DNA blood mini kits (Qiagen, Hilden, Germany) according to the manufacturer's instructions. After quantification, these DNA samples were subjected to DNA genotyping using the TaqMan SNP Genotyping Assay. Briefly, genomic DNA samples of 10 ng each were amplified using PCR in a total volume of 5 μL containing TaqMan Universal Master Mix, 80x SNP Genotyping AssayMix, DNase-free water and 10-ng DNA. The PCR conditions were 50 
Cell line, culture, and miR-2861 transfection
Embryonic Kidney 293T cells were obtained from the Chinese Academy of Sciences Cell Bank (Shanghai, China) and cultured in RPMI-1640 (Gibco, Gaithersburg, MD, USA) supplemented with 10 % fetal bovine serum (Invitrogen, Carlsbad, CA, USA) in a humidified incubator with 5 % CO 2 at 37 o C. The miR-2861 mimics and control were obtained from Genepharma (Shanghai, China) and transfected into 293T cells using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol.
Construction of luciferase-based reporter plasmids and luciferase reporter assay MTHFR 3'-UTR fragments containing either A or G alleles were amplified using PCR from genomic DNA and cloned into pGL3-promoterless luciferase-based plasmids (Promega, Madison, WI, USA) multiple cloning sites. MTHFR 3'-UTR fragments potentially binding to miR-2861, predicted by bioinformatics analysis or a mutated sequence with the predicted target sites, were cloned using PCR from genomic DNA and inserted into the pGL3 promoter vector (Genscript, Nanjing, China). The cloned plasmids were amplified and verified by DNA sequencing. Next, 293T cells were plated onto 24-well plates and transfected with 100 ng of pGL3-MTHFR wild, pGL3-MTHFR mutant, and miR-2861 mimics, respectively. A Renilla luciferase vector pRL-SV40 (5ng) was also co-transfected as a normalization and transfection efficiency control. Each experiment was performed in triplicate and luciferase activity was assessed 48h after transfection using the dual-luciferase reporter assay system (Promega). Firefly luciferase activity was normalized to Renilla luciferase activity.
ELISA of plasma homocysteine levels
Plasma levels of tHcy in patients was assessed using a tHcy ELISA kit (Green Stone, Bern, Switzerland), according to the manufacturer's protocol. The level of plasma tHcy was normalized to the kit standard and the data were summarized as Mean ± SD.
Statistical analysis
The association between different genetic variants and ischemic stroke risk was evaluated by calculation of the odds ratios (ORs) and 95% confidence intervals (CIs) using univariate and multivariate logistic regression analysis. The difference in association of MTHFR mRNA levels with three MTHFR genotypes and of the relative luciferase activity between the wild and mutant genotype were evaluated by using an independent-sample t test. All statistical analyses were two-sided and P<0.05 was considered statistically significant using SPSS 13.0 (SPSS, Chicago, IL, USA) or SAS software (version 9.1.3; SAS Institute, Cary, NC, USA).
Results
Characteristics of participants
Characteristics of patients with atherosclerosis and healthy controls are shown in Table 1 . Specifically, the controls were matched with cases for age and gender. Cigarette smoking (P <0.001), alcohol consumption (P <0.001), diabetes and hypertension (P <0.001), a low level of serum high-density lipoprotein-C (HDL-C; P = 0.02) were significantly associated with ischemic stroke.
Cellular
However, BMI and total serum cholesterol concentration were not associated with ischemic stroke (Table1).
Identification of MTHFR polymorphisms in 3'-UTR
In this study, we mainly focused on the relationship of the SNPs in the MTHFR 3'-UTR to ischemic stroke risk and outcome. We first searched the GenBank of Single Nucleotide Polymorphism (SNP) database (https:// www.ncbi.nlm.nih.gov/snp) to identify potential MTHFR genetic variants in the 3'-UTR using the following parameters: Organism (Homo sapiens); Function Class (3'-UTR); Global MAF (0.05-0.1); Validation Status (by-1000 Genomes). We identified five MTHFR polymorphisms ( Table 2) .
We then assessed genotype frequencies of these five MTHFR SNPs in 500 atherosclerosis patients and 600 healthy controls. We found that the MTHFR SNP rs915014 had a statistically different distribution between atherosclerosis patients and healthy controls. The Chisquare test confirmed that the genotype of rs915014 was in Hardy-Weinberg equilibrium distribution pattern in the healthy control group (P = 0.32). Table 3 ). A higher number of G-alleles were also associated with an increased risk of ischemic stroke (OR: 1.68; 95 %CI: 1.29-2.65).
Association of the MTHFR rs915014 SNP with a poor atherosclerosis outcome
Next, we assessed the association of the MTHFR rs915014 SNP with atherosclerosis outcome. The Gensini score system was applied to evaluate the outcome of atherosclerosis. We found that patients carrying either the MTHFR rs915014 AG or GG genotype had an increased Gensini score. Moreover, we assessed levels of MTHFR mRNA in patients carrying the MTHFR rs915014 AA, AG and GG genotypes. Our data showed that patients carrying the MTHFR rs915014 AG or GG genotypes had a higher level of MTHFR compared with patients with the AA genotype. We then assayed levels of serum tHcy in patients and found that patients carrying the MTHFR rs915014 AG or GG genotype were associated with the accumulation of serum tHcy (Table 4) .
MTHFR rs915014 SNP alteration of miR-2861 binding
Thus far, we revealed that the MTHFR rs915014 SNP was associated with risk and poor ischemic stroke outcome. We then performed bioinformatics analysis to determine whether this MTHFR rs915014 SNP could have miRNA binding sites. We found that miR-2861 could bind to this particular SNP of the minor allele (Fig. 1A) . We therefore performed a luciferase assay to confirm such binding and found that luciferase activity of G-allele-specific pGL3 construct was significantly suppressed by miR-2861. Luciferase activity of the A-allelespecific pGL3 construct was not altered by miR-2861 transfection in 293T cells (Fig. 1B, C) .
Discussion
In this study, we demonstrated the important value of MTHFR rs915014 polymorphism with the higher risk of human atherosclerosis. Mechanistically, the MTHFR rs915014 polymorphism alters the binding of miR-2861 to negatively regulate MTHFR expression, providing an epigenetic mechanism of gene regulation and expression. In this field, it was the first time to reveal the functional SNP located in the 3'UTR of MTHFR acting as a risk factor for the atherosclerosis.
MTHFR is an important enzyme in the generation of ROS and subsequent cell damage. Indeed, in ischemic conditions, ROS generation is enhanced and can lead to damage to various types of cells, including brain endothelial cells, leading to formation of thrombosis and loss of brain function. Our current study provides direct evidence showing that this novel MTHFR rs915014 polymorphism increases the risk of atherosclerosis compared with healthy controls. For the polymorphism of MTHFR, researchers has also found the susceptibility in human cancer disease. For example, One SNP, rs9651118 located in MTHFR, was associated with disease recurrence, and the association persisted after multivariate analyses adjusting for known risk factors [18] . Further PCR analysis revealed that MTHFR expression is significantly upregulated in prostate tumor tissues when compared with 
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Cellular Physiology and Biochemistry adjacent normal tissues. In human esophageal squamous cell carcinoma (ESCC), the rs114673809 A allele carrier also showed a 1.286-fold increased ESCC risk compared with those carrying the rs114673809 G allele genotype. Furthermore, a significant increase in plasma homocysteine levels in ESCC cases carrying the AA genotype relative to ESCC cases carrying the GG genotype were observed [19] . According to the traditional function of MTHFR, polymorphisms in the gene that codes for MTHFR result in production of an enzyme with decreased activity, an anomaly that can have an impact on a myriad of biochemical processes. Ultimately MTHFR SNPs can cause hyperhomocysteinemia (especially if folate levels are low); affect nervous system, behavioral, and vascular health; contribute to birth defects, miscarriage, and preeclampsia; modulate cancer risk and finally, could increase the risk of atherosclerosis [20] [21] [22] . Homocysteine is a potentially toxic, sulfur-containing amino acid that must be kept in check; without proper processing, it can build up and cause tissue and organ damage. Elevated blood levels and accumulation of homocysteine are associated with a variety of anomalies including birth defects, diabetes, renal disease, osteoporosis, and vascular, immune, neurodegenerative, and neuropsychiatric disorders [23] . Elevated serum homocysteine is considered an independent risk factor for vascular disease and related complications such as myocardial infarction, stroke, and venous thrombosis [24] . There is accumulating evidence demonstrating that SNPs localized at miRNA binding sites (miRSNPs) could affect the binding of miRNAs to the target genes and in turn result in reduction or increase in translation of the target mRNA and altered susceptibility to cancer. For example, previous studies showed that the rs2910164 polymorphism harboring the sequence for miR-146a could influence susceptibility to gastric cancer in a Chinese population, while rs4143815 and rs4819388 SNPs in the 3'-UTR of B7-H1 and B7-H2 genes, respectively, associated with development of gastric cancer.
Conclusion
In summary, our current study demonstrated that the function SNP rs915014 in the 3'UTR of MTHFR AG and GG genotypes were associated with increased risk of atherosclerosis compared with the GG genotype. The miR-2861 is able to bind to MTHFR with G allele and down-regulate MTHFR expression resulting in an increased level of serum tHcy and a poor atherosclerosis outcome. The detection of rs915014 in atherosclerosis combining with tHcy might be a possible prognosis biomarker in the future.
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